Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED
SPE2D2-24-R-0016 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2025-02-14. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
July 10,2024, Amendment 004 is hereby issued to cancel the subject solicitation in it's entirety The Defense Logistics Agency is issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow. DESCRIPTION EST QTY (YR
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
Questions
What is solicitation SPE2D2-24-R-0016?
Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING). Responses are due 2025-02-14.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.